Evidence map›Paper›PMID 34220715›Full record

ArticleFrontiers in endocrinology2021

The Value of Different Single or Combined Indexes of the Captopril Challenge Test in the Diagnosis of Primary Aldosteronism.

Qiao Xiang, Tao Chen, Kai Yu, Yuanmei Li, Qianrui Li, Haoming Tian, Yan Ren

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Qiao XiangDepartment of Endocrinology and Metabolism, Adrenal Center, Sichuan University West China Hospital, Chengdu, China.
Tao ChenDepartment of Endocrinology and Metabolism, Adrenal Center, Sichuan University West China Hospital, Chengdu, China.
Kai YuDepartment of Endocrinology and Metabolism, Adrenal Center, Sichuan University West China Hospital, Chengdu, China.
Yuanmei LiDepartment of Endocrinology and Metabolism, Suining Central Hospital, Suining, China.
Qianrui LiDepartment of Nuclear Medicine, Sichuan University West China Hospital, Chengdu, China.
Haoming TianDepartment of Endocrinology and Metabolism, Adrenal Center, Sichuan University West China Hospital, Chengdu, China.
Yan RenDepartment of Endocrinology and Metabolism, Adrenal Center, Sichuan University West China Hospital, Chengdu, China.
West China Hospital of Sichuan University · CNSichuan University · CNSuizhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The result interpretation of the captopril challenge test (CCT) for the diagnosis of primary aldosteronism (PA) is not standardized. Superiorities of different indexes in the CCT have not been fully investigated. We aimed to comprehensively evaluate the value and influence factors of different CCT-associated indexes in the diagnosis of PA. Methods: We enrolled 312, 85, 179 and 97 patients in the groups of PA, essential hypertension (EH), unilateral PA (UPA) and bilateral PA (BPA), respectively. For each single index investigated, we computed diagnostic estimates including the area under the receiver operating characteristic curve (AUC). We performed pre-specified subgroup analyses to explore influence factors. We assessed the diagnostic value of combined indexes in binary logistic regression models. Results: Post-CCT aldosterone to renin ratio (ARR) (AUC = 0.8771) and plasma aldosterone concentration (PAC) (AUC = 0.8769) showed high value in distinguishing PA from EH, and their combination (AUC = 0.937) was even superior to either alone. The diagnostic efficacy was moderately high for post-CCT aldosterone to angiotensin II ratio (AA2R) (AUC = 0.834) or plasma renin activity (PRA) (AUC = 0.795) but low for the suppression percentage of PAC (AUC = 0.679). Post-CCT PAC had a significantly higher AUC in the UPA than BPA subgroup (AUC = 0.914 Conclusion: We can take post-CCT ARR and PAC altogether into account to distinguish PA from EH, while caution should be taken to interpret CCT results with the suppression percentage of PAC. Post-CCT PAC may perform better to identify the unilateral than bilateral form of PA.

Indexed as

AldosteroneCaptoprilFemaleHumansHyperaldosteronismMaleMiddle AgedReninROC CurveAldosteroneCaptoprilReninaldosterone to renin ratiocaptopril challenge testdiagnosisessential hypertensionprimary aldosteronism

Identifiers

PMID34220715
PMCPMC8247899
OpenAlexW3174441959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.